Dr. Mark Hyman warns standard labs miss early metabolic decay
- Standard blood tests miss early metabolic failure by ignoring fasting insulin levels.
- Unmonitored GLP-1 weight loss drugs trigger muscle decay without heavy resistance training.
- Direct-to-consumer lab panels and AI models catch disease years before physical symptoms appear.
Standard medicine catches disease far too late.
Speaking on This Week in Startups, Function Health co-founder Dr. Mark Hyman argued that routine blood panels ignore the earliest signals of cellular decay. Physicians consistently monitor fasting blood glucose, but glucose is a lagging indicator. By the time blood sugar spikes, metabolic dysfunction has already damaged tissue for years. Fasting insulin provides the real baseline, yet Quest Diagnostics includes it in less than one percent of lab orders.
Data from Function Health reveals that 65 percent of its tested members show elevated fasting insulin levels despite normal blood glucose. Traditional practice bypasses these markers because standard pharmaceuticals target full-blown disease rather than early dysfunction. Meanwhile, financial friction keeps patients away, with one in three Americans delaying medical visits due to cost.
AI interpretation and direct consumer lab access are dismantling that bottleneck.
Function Health tracks 160 biomarkers twice a year for a dollar a day, replacing clinic visits that historically cost up to $15,000. Large language models now evaluate these multi-omic panels with accuracy rivaling individual physicians. Pairing direct lab access with doctor-in-the-loop AI validation allows patients to intercept trajectories toward Alzheimer's and diabetes long before symptoms materialize.
Hyman also targeted the widespread overuse of GLP-1 weight loss medications. While effective at driving rapid scale drop, up to 75 percent of users endure gastrointestinal side effects and four percent suffer severe adverse events. Without forced resistance training and high protein intake, patients shed essential muscle mass alongside fat, destroying their basal metabolic rate and guaranteeing weight rebounds once injections stop.
The misreading of biological distress extends directly into mental healthcare. Modern psychiatry regularly prescribes SSRIs and stimulants for biological failures rooted in systemic inflammation and nutrient deficits. Deficiencies in omega-3 fatty acids, vitamin D, and B vitamins frequently manifest as clinical depression, while ultra-processed foods inflame the brain. In institutional trials, replacing processed foods with whole foods slashed violent incidents in juvenile detention facilities by 97 percent.
True health management requires continuous cellular data, not reactive prescription bottles.